Literature DB >> 1931735

A comparative study of diazepam levels in bone marrow versus serum, saliva and brain tissue.

T Takatori1, S Tomii, K Terazawa, M Nagao, M Kanamori, Y Tomaru.   

Abstract

The distribution of diazepam in biological fluids and tissues of rats was examined 1, 2, 4 and 8 h after intraperitoneal administration by using a radioimmunoassay with specific anti-diazepam antibody. The diazepam levels in serum, saliva, brain and bone marrow decreased over a period of 2 h and levelled off 4 h after administration. The diazepam concentration in bone marrow was much higher than in serum, saliva and brain, suggesting an accumulation of diazepam in this tissue. This indicates that bone marrow could be a very useful material for the detection of diazepam in skeletonized remains. The diazepam concentrations in bone marrow, serum, saliva and brain showed a linear relationship (r = 0.860-0.997), indicating that a valid estimate of diazepam concentration in blood can be made from bone marrow samples.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931735     DOI: 10.1007/bf01369803

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  15 in total

1.  C14-Cholesterol. IV. Oxidation of carbons 4 and 26 to carbon dioxide by surviving tissues.

Authors:  J R MEIER; M D SIPERSTEIN; I L CHAIKOFF
Journal:  J Biol Chem       Date:  1952-09       Impact factor: 5.157

2.  Radioimmunoassay technology in mass drug screening: an evaluation of an absorbent paper disk transport system.

Authors:  E R Noe; G D Lathrop; C A Ainsworth; J H Merritt
Journal:  J Forensic Sci       Date:  1976-04       Impact factor: 1.832

3.  Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding.

Authors:  C Braestrup; R F Squires
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

4.  Use of saliva in therapeutic drug monitoring.

Authors:  M G Horning; L Brown; J Nowlin; K Lertratanangkoon; P Kellaway; T E Zion
Journal:  Clin Chem       Date:  1977-02       Impact factor: 8.327

5.  Further studies on species difference in diazepam metabolism.

Authors:  F Marcucci; R Fanelli; E Mussini; S Garattini
Journal:  Eur J Pharmacol       Date:  1970-02       Impact factor: 4.432

6.  Blood level distribution patterns of diazepam and its major metabolite in man.

Authors:  J A De Silva; B A Koechlin; G Bader
Journal:  J Pharm Sci       Date:  1966-07       Impact factor: 3.534

7.  Metabolism of diazepam in rat, dog, and man.

Authors:  M A Schwartz; B A Koechlin; E Postma; S Palmer; G Krol
Journal:  J Pharmacol Exp Ther       Date:  1965-09       Impact factor: 4.030

8.  Detection of drugs in a bloodstain. I: diphenylhydantoin.

Authors:  R C Shaler; F P Smith; C E Mortimer
Journal:  J Forensic Sci       Date:  1978-10       Impact factor: 1.832

9.  Specificity of an antibody directed against d-methamphetamine. Studies with rigid and nonrigid analogs.

Authors:  B A Faraj; Z H Israili; N E Kight; E E Smissman; T J Pazdernik
Journal:  J Med Chem       Date:  1976-01       Impact factor: 7.446

10.  Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.

Authors:  U Klotz; K H Antonin; P R Bieck
Journal:  J Pharmacol Exp Ther       Date:  1976-10       Impact factor: 4.030

View more
  3 in total

Review 1.  State-of-the-art of bone marrow analysis in forensic toxicology: a review.

Authors:  Nathalie Cartiser; Fabien Bévalot; Laurent Fanton; Yvan Gaillard; Jérôme Guitton
Journal:  Int J Legal Med       Date:  2011-03       Impact factor: 2.686

2.  Using bone marrow matrix to analyze meprobamate for forensic toxicological purposes.

Authors:  F Bévalot; M P Gustin; N Cartiser; Y Gaillard; C Le Meur; L Fanton; J Guitton; D Malicier
Journal:  Int J Legal Med       Date:  2013-02-12       Impact factor: 2.686

Review 3.  Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants.

Authors:  H Liu; M R Delgado
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.